Sensys Gatso Group AB logo

Sensys Gatso Group AB (SGG)

Market Closed
10 Aug, 15:25
XSTO XSTO
kr
41. 00
+1.2
+3.0151%
kr
- Market Cap
- P/E Ratio
- Div Yield
16,877 Volume
0 Eps
kr 39.8
Previous Close
Add Transaction
Day Range
39.8 42.2
Year Range
34.55 48.4
Want to track SGG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SGG closed today higher at kr41, an increase of 3.0151% from yesterday's close, completing a monthly increase of 8.8977% or kr3.35. Over the past 12 months, SGG stock gained 5.1282%.
SGG is not paying dividends to its shareholders.
The last earnings report, released on May 07, 2026, exceeded the consensus estimates by 0.5%. On average, the company has surpassed earnings expectations by 0.24%, based on the last three reports.
Sensys Gatso Group AB has completed 1 stock splits, with the recent split occurring on Jun 15, 2023.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

SGG Chart

Sensys Gatso Group AB (SGG) FAQ

What is the stock price today?

The current price is kr41.00.

On which exchange is it traded?

Sensys Gatso Group AB is listed on XSTO.

What is its stock symbol?

The ticker symbol is SGG.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Sensys Gatso Group AB ever had a stock split?

Sensys Gatso Group AB had 1 splits and the recent split was on Jun 15, 2023.

Sensys Gatso Group AB Profile

- Industry
- Sector
Mr. Martin Dillon CEO
XSTO Exchange
SE0020356244 ISIN
AU Country
- Employees
- Last Dividend
15 Jun 2023 Last Split
- IPO Date

Overview

TruScreen Group Limited, initially known as TruScreen Limited, is a company specializing in the development, manufacture, and global sale of innovative cancer detection devices and systems. Established in 2013 and undergoing a name change in August 2020, the company has expanded its reach to various international markets including Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East, and North Africa. With its headquarters in Auckland, New Zealand, TruScreen aims to contribute significantly to early cancer detection and prevention efforts worldwide.

Products and Services

  • TruScreen Cervical Cancer Screening Device
  • This medical device is at the forefront of TruScreen's product line, offering a cutting-edge solution for real-time identification and detection of precancerous and cancerous tissue on the cervix. Designed to enhance the effectiveness and accessibility of cervical cancer screening globally, this device aligns with the company’s mission of improving women's health outcomes.

Contact Information

Address: Equitable House, Auckland, New Zealand, 1010
Phone: 61 2 8999 3896